Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KANAMYCIN A: 88 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
88
Total FAERS Reports
16 (18.2%)
Deaths Reported
16
Hospitalizations
88
As Primary/Secondary Suspect
2
Life-Threatening
2
Disabilities

Active Ingredient: KANAMYCIN A SULFATE ·

First Report: 2017 · Latest Report: 20221214

What Are the Most Common KANAMYCIN A Side Effects?

#1 Most Reported
Drug resistance
21 reports (23.9%)
#2 Most Reported
Treatment failure
18 reports (20.5%)
#3 Most Reported
Electrocardiogram qt prolonged
10 reports (11.4%)

All KANAMYCIN A Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug resistance 21 23.9% 5 4
Treatment failure 18 20.5% 10 2
Electrocardiogram qt prolonged 10 11.4% 2 0
Anaemia 6 6.8% 0 1
Drug reaction with eosinophilia and systemic symptoms 6 6.8% 0 0
Hepatotoxicity 6 6.8% 0 4
Multiple-drug resistance 6 6.8% 4 1
Nausea 6 6.8% 1 1
Off label use 6 6.8% 2 2
Pathogen resistance 6 6.8% 1 2
Deafness 5 5.7% 1 0
Depression 5 5.7% 1 0
Drug ineffective 5 5.7% 0 0
Neuropathy peripheral 5 5.7% 1 0
Treatment noncompliance 5 5.7% 2 2
Vomiting 5 5.7% 1 1

Who Reports KANAMYCIN A Side Effects? Age & Gender Data

Gender: 51.9% female, 48.1% male. Average age: 41.4 years. Most reports from: US. View detailed demographics →

Is KANAMYCIN A Getting Safer? Reports by Year

YearReportsDeathsHosp.
2017 6 0 2
2018 5 0 0
2019 2 1 2
2022 1 0 1

View full timeline →

What Is KANAMYCIN A Used For?

IndicationReports
Tuberculosis 51
Pulmonary tuberculosis 17
Bacterial infection 6
Product used for unknown indication 5

Official FDA Label for KANAMYCIN A

Official prescribing information from the FDA-approved drug label.